Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008;Adherencia al programa poblacional de detección precoz de cáncer colorrectal en Cataluña, 2000-2008

Gaceta Sanitaria

Volumn 26, Issue 3, 2012, Pages 217-222

  Milà, Núria ^a   García, Montse ^a   Binefa, Gemma ^a   Borràs, Josep Maria ^a,b,c   Espinàs, Josep Alfons ^a,b,c   Moreno, Víctor ^a,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Generalitat de Cataluña   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adherence; Colorectal cancer; Early detection; Participation; Screening

Indexed keywords

AGED; ARTICLE; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ATTITUDE; SPAIN; STATISTICS;

AGED; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SPAIN;

EID: 84861457200     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/j.gaceta.2011.10.020     Document Type: Article

References (27)

1. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781.
2. López-Abente G., Ardanaz E., Torrella-Ramos A., et al. Changes in colorectal cancer incidence and mortality trends in Spain. Ann Oncol 2010, 21(Suppl 3):iii76-iii82.
3. Advisory Committee on Cancer Prevention. Eur J Cancer 2000, 36:1473-1478. Recommendations on cancer screening in the European union.
4. Council Recommendation of 2 December 2003 on cancer screening. Official J Eur Union. 2003; 2003/878/EC:34-8.
5. Estrategia Nacional del Cáncer 2009, Ministerio de Sanidad y Consumo, Ministerio de Sanidad y Consumo, Madrid.
6. Mandel J.S., Bond J.H., Church T.R. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993, 328:1365-1371.
7. Krönborg O., Fenger C., Olsen J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471.
8. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
9. Gellad Z.F., Stechuchak M.M., Fisher D.A., et al. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol 2011, 106:1125-1134.
10. Conner M., Norman P. Predicting health behavior: research and practice with social cognition models 1996, Open University Press, Philadelphia.
11. Wardle J., Sutton S., Williamson S., et al. Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med 2000, 31:323-334.
12. Weinstein N.D. Testing four competing theories of health behavior. Health Psicol 1993, 12:324-333.
13. Brewer N.T., Weinstein N.D., Cuite C.L., et al. Risk perceptions and their relation to risk behavior. Ann Behav Med 2004, 27:125-130.
14. Steckelberg A., Kasper J., Redegels M., et al. Risk information - barrier to informed choice?. A focus group study. Soz Präventivmed 2004, 49:375-380.
15. Robb K.A., Miles A., Wardle J. Subjective and objective risk of colorrectal cancer (UK). Cancer Causes Control 2004, 15:21-25.
16. Peris M., Espinas J.A., Muñoz L., et al. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen 2007, 14:81-86.
17. Ascunce N., Salas D., Zubizarreta R., et al. Cancer screening in Spain. Ann Oncol 2010, 21(Suppl 3):iii43-iii51.
18. Lynn P, Beerten R, Laiho J, et al. Recommended standard final outcome categories and standard definitions of response rate for social surveys. Working Papers of the Institute for Social and Economic Research, paper 2001-23. Colchester: University of Essex; 2001.
19. Garcia M., Borràs J.M., Milà N., et al. Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study. Prev Med 2011, 52:265-267.
20. Weller D.P., Patnick J., McIntosh H.M., et al. Uptake in cancer screening programs. Lancet 2009, 10:693-699.
21. Rawl S.M., Menon U., Champion V.L., et al. Do benefits and barriers differ by stage of adoption for colorectal cancer screening?. Health Educ Res 2005, 20:137-148.
22. Farraye F.A., Wong M., Hurwitz S., et al. Barriers to endoscopic colorectal cancer screening: are women different from men?. Am J Gastroenterol 2004, 99:341-349.
23. Senore C., Malila N., Minozzi S., et al. How to enhance physician and public acceptance and utilisation of colon cancer screening recommendation. Best Pract Res Clin Gastroenterol 2010, 24:509-520.
24. Huang C.S., Lal S.K., Farraye F.A. Colorrectal cancer screening in average risk individuals. Cancer Causes Control 2005, 16:171-188.
25. Hou S., Chen P. Cancer screening beliefs and reactions to an innovative colorrectal cancer screening kit among chinese worksite population. Methods Inf Med 2005, 44:315-318.
26. Clavarino A.M., Janda M., Hughes K.L., et al. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT. Prev Med 2004, 39:482-490.
27. Bain N.S.C., Campbell N.C., Rithchie L.D., et al. Striking the right balance in colorrectal cancer care - a qualitative study of rural and urban patients. Fam Practice 2002, 19:369-373.